Generative AI pioneers novel antibiotics that disrupt bacterial cell membranes, offering potential solutions against drug-resistant gonorrhea, MRSA, and other superbugs in the ongoing battle against antimicrobial resistance.
Groundbreaking AI models generate novel antibiotics NG1 and DN1 that effectively combat multidrug-resistant superbugs like gonorrhea and MRSA, iteratively building and optimizing molecular structures for potency and safety.
Cleveland Clinic and startup Piramidal unveil an AI model that monitors brain health of ICU patients in real-time by analyzing EEG data and flagging abnormalities within seconds, enabling doctors to intervene promptly.
Apple unveils a groundbreaking App Intents feature and revamped Siri experience, slated for a spring launch, enabling Siri to seamlessly interact with apps while navigating sensitive scenarios like health and banking with precision.
Google and NASA unveil an AI medical assistant that uses natural language processing and machine learning to autonomously diagnose symptoms and recommend treatments for astronauts in space, with promising early trial results and further refinement planned in collaboration with doctors.
OpenAI unveils GPT-5, its latest flagship AI model, powering advanced ChatGPT capabilities like generating software applications, navigating calendars, and excelling in coding, healthcare, and creative design while reducing hallucinations and deception.
In a groundbreaking development, scientists unveil an AI model capable of accurately pinpointing the location of any protein within human cells, combining protein language models and computer vision to capture intricate details, potentially revolutionizing disease diagnosis, drug target identification, and our understanding of biological processes.
Major tech companies are implementing safeguards as concerns arise over users seeking mental health advice from AI chatbots, while several states regulate or prohibit the use of AI systems for direct mental health services, posing challenges for investment firms betting on AI therapy chatbots.
A groundbreaking brain-computer interface developed by Synchron enables a person with ALS to control an iPad using only their thoughts, seamlessly integrating with Apple's accessibility features for native, thought-driven control of the device.
Federal funding cuts leave US biomedical research in crisis as UMass Chan Medical School receives only $2 million in grants versus the typical $25-30 million, while private investors focus on short-term commercial projects rather than basic science, creating a devastating $23 million funding gap.